www.alk.net
  • Patients
    • What is allergy
      • House dust mite allergy
      •  
      • Pollen allergy
      •  
      • Living with allergy
      •  
      • Socio-economic impact
      •  
    •  
    • What is allergic asthma
    •  
    • How is allergy diagnosed
    •  
    • Treating allergy
    •  
  •  
  • Healthcare Professionals
    • Treating allergy and asthma
    •  
    • Products
    •  
    • Adverse reactions
    •  
    • Initiation of treatment
    •  
    • Clinical trials
    •  
  •  
  • R&D
    • R&D pipeline
    •  
    • Understanding immunotherapy
    •  
    • Research
    •  
    • Congress activities
    •  
    • Clinical data sharing
    •  
  •  
  • Careers
    • Working at ALK
    •  
    • Vacant positions
    •  
  •  
  • Investors
    • Overview
    •  
    • Financial reporting
      • Risk management
      •  
      • Reporting standards
      •  
      • Auditors
      •  
    •  
    • Governance
      • IR policy
      •  
      • Management
      •  
      • Board of directors
      •  
      • Annual general meeting
      •  
      • Annual general meeting (DK)
      •  
    •  
    • News & Events
      • Company Releases
      •  
      • Company releases (DK)
      •  
      • Webcasts & presentations
      •  
      • Investor calendar
      •  
    •  
    • The Share
      • Dividend history
      •  
      • Analyst coverage
      •  
      • Analyst estimates
      •  
      • Shareholder information
      •  
      • Authorizations
      •  
      • ADR Programme
      •  
    •  
    • Contact IR
    •  
    • Management
    •  
    • Board of directors
    •  
    • AGM
    •  
    • AGM (DK)
    •  
    • Nyheder
    •  
    • Nyheder (EN)
    •  
  •  
  • Media
  •  
  • About
    • ALK at a glance
    •  
    • CSR
    •  
    • Production
    •  
    • Global presence
    •  
    • Organisation
    •  
    • History
    •  
    • Values
    •  
    • Owners
    •  
  •  
  • Select country
  •  
Search

Analyst coverage

Links: 
Dividend history
Analyst coverage
Analyst estimates
Shareholder information
Authorizations
ADR Programme

ALK is covered by the following analysts.

ABG Sundal Collier

Jannick Lindegaard Denholt

jannick.denholt@abgsc.dk
Phone: +45 33 18 61 00

Carnegie Danmark

Jesper Ilsøe

Jesper.Ilsoe@carnegie.dk
Phone: +45 32 88 02 00

Danske Equities

Thomas Bowers

thomas.bowers@danskebank.dk
Phone: +45 33 44 00 00

DNB Bank ASA

Jesper Ingildsen

jesper.ingildsen@dnb.no
Phone: +44 20 7621 1111

Handelsbanken

Peter Sehested

pese10@handelsbanken.dk
Phone: +45 33 41 82 00

Jefferies International

Peter Welford

pwelford@jefferies.com
Phone: +44 (0) 20 7029 8000

Kempen & Co N.V.

Alex Cogut

Alex.Cogut@kempen.com
Phone: + 31 20 - 348 8000

Nordea

Michael Novod

michael.novod@nordea.com
Phone: +45 33 33 33 33

SEB Enskilda

Yiwei Zhou

yiwei.zhou@seb.dk
Phone: +46 8 52 22 95 00

Sydbank

Søren Løntoft Hansen

s.loentoft@sydbank.dk
Phone: +45 74 36 36 36

Please note that any opinions, estimates or forecasts regarding ALK's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ALK or its management. ALK does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

 
  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved